Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IP Risk Control Signs Letter Intent Acquire ARALOC.com
Jun 12, 2017
OTC Disclosure & News Service
Salt Lake City, UT -
SharePrint
June 12, 2017 08:30 ET | Source: Appiphany Technologies Holdings Corp.
SALT LAKE CITY, June 12, 2017-- Continuing its expansion into cloud-based data protection and management, IP Risk Control (OTCPK:APHD), signed a letter of intent to acquire all technology, sales assets and customers of Modevitys enterprise cloud-based data storage, protection and workflow automation platform, ARALOC.
ARALOC is an industry-leading secure digital content distribution and communications platform that protects an organizations confidential content and intellectual property assets from leakage malicious or accidental without impacting communications and collaboration between all stakeholders.
Originally developed in 2004, ARALOC is one of the industrys first products to deliver on a SaaS-Based approach with full encryption and digital rights management for all kinds of content fully controlled and maintained directly by the customer - with a high level of content security, audit trails and analytics to support todays ever-increasing information security regulations such as HIPAA, Sarbanes-Oxley, ITAR, Gramm-Leach-Bliley Act and others.
The platform is natively based on the Microsoft Azure cloud infrastructure and integrates with Microsoft Active Directory (Azure & on premise) for a seamless single sign on experience. The ARALOC platform maintains a full set of RESTFul APIs for easy integration to any upstream or downstream application.
When I first saw the ARALOC product and reviewed its architecture with the team, I knew we had a technology winner. Knowing that it has over 400 active clients and has almost a decade of sales and operations behind it further validates the market acceptance of the product line, states IP Risk Controls President Jason Remillard. Indeed, when multi-billion dollar global organizations rely on it for secure content distribution for their most critical information renewing their service for years now we are honored to continue those relationships, build and augment the product functionality and enhance its offerings ongoing.
The ARALOC platform includes: SPARK Employee Communications Platform, Board Management Software, Sales Content Management, and publishing/distribution of content for K-12 educational clients.
The IP Risk Control team is building an incredible and on-target technology stack that is relevant and highly-required for today's information security requirements, added Modevity, LLC President and co-Founder Jim Coyne. Combining ARALOC with functions such as ClassiDocs and other enhancements signifies both a deep understanding of the market and a continued leading data governance and storage management platform which is able to be deeply integrated to the rest of enterprise for both cloud and hybrid-cloud applications.
The teams are working closely to complete the transition as efficiently as possible, while continuing to grow the customer base and product set. We expect the transaction to be accretive to earnings beginning Q2 FY 2018 and ongoing. The transaction includes the full and completely supported transition of customers, code, sales and marketing and other operational facets of the business. We are very excited to add this solution set to our offerings for our clients, added IP Risk Control president Jason Remillard.
Customers, analysts and reporters that are interested in the technology and a roadmap briefing with the team will be able to learn how the product integrates with the main strategy of IP Risk Control and how it is positioned to be significantly differentiated from other data governance, data classification and Data Access Governance vendors solutions.
Terms of the transaction were not disclosed.
Follow news directly at:
http://ipriskcontrol.com/blog/
https://twitter.com/IPRiskControl
About Appiphany Technology Holdings Corp.
Appiphany Technologies (IP Risk Control) (http://www.ipriskcontrol.com) has diversified offerings to deliver global 'best-of-breed' products and technologies that combat counterfeit and theft of global goods, data and cyber security protection. The Company continues to develop its own technologies and has an active acquisitions program in place.
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Appiphany's filings with the SEC, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Contact Info:
http://www.araloc.com
http://www.ipriskcontrol.com
http://www.classidocs.com
Media Relations
info@ipriskcontrol.com
+1-385-212-3295
Copyright © 2017 OTC Markets. All Rights Reserved
shes thin just need volume.....006 2 months ago.
LETS GO PARTY PEOPLE....NEED VOLUME..
TWO MONTH HIGHS - .0065...NEED BIG BIDDER
VNDM GONE
$APHD NEWS OUT....60Million!! BID .0008x.0009 +50%%%%%%%%
Tuesday, June 20 2017 8:30 AM, EST IP Risk Controls ClassiDocs Releases Encrypted File Detection Functionality GlobeNewswire "Press Releases"
SALT LAKE CITY , June 20, 2017 (GLOBE NEWSWIRE) -- ClassiDocs unveiled new functionality that enables any organization to be notified when a portion of their files have become encrypted usually a harbinger to a Malware or Ransomware infection. With continued proliferation of ransomware infections and their mutations by hackers and some nation-states the risk of a ransomware infection getting past normal defenses continues to grow.
Many of our customers and partners are looking past the prevention boundary and are focusing on the response side. Response is critical in any cyber-security program and having these being automated but guided by data intelligence is significant," stated IP Risk Control (OTCPNK:APHD) President Jason Remillard . While front line defense will always be important, how you respond to actual events ranks very highly in mitigating risk, costs and ultimately the damage done.
The newest functionality leverages the existing distributed agent real estate to monitor file activity not just reads and writes, but what is in them and how they are classified. If a certain percentage of them are detected to be encrypted the administrator can automatically run processes that are appropriate. In most cases, this would mean immediately disconnecting and shutting down the machine, locking out the user in question and sending alerts to the cyber security operations center. Administrators can control the sequence of events and orchestrations in response to the encryption (or ransomware) condition.
ClassiDocs is a leading Data Classification platform that enables End Users and Data Stewards to actively participate in the process of classifying data sets (structured and unstructured) in a user-friendly, efficient and quick process that generally requires little to no end user training or education. The entire solution is quick to deliver value for the organization - with average installation and configuration times to be less than 1 hour from installation to time to value.
By enabling the business to make IT decisions based on a potentially hostile action such as a mass encryption of files - ClassiDocs brings actual data intelligence to the IT and governance teams. In the case of a WannaCry or other related attacks, the ultimate impact of the damage done can be greatly reduced," continues Remillard.
The ability to classify data sets in myriad platforms - with an accurate and up-to-date classification system - is integral for any organization (health care, financial services, manufacturing, government) with private, customer, or financial information to protect. ClassiDocs represents a departure from the regular approaches - with its focus on end-user adoption, simple and rapidly deployable architecture, and native integrations with leading SIEM, EndPoint Security and Governance and Compliance toolsets.
ClassiDocs was acquired by Appiphany Technology Holdings Corp. in April 2017 .
IP Risk Control is Hiring! - http://ipriskcontrol.com/jobs/
Follow news directly at:
http://ipriskcontrol.com/blog/
https://twitter.com/IPRiskControl
About Appiphany Technology Holdings Corp.
Appiphany Technologies (IP Risk Control) (http://www.ipriskcontrol.com) has diversified offerings to deliver global 'best-of-breed' products and technologies that combat counterfeit and theft of global goods, data and cyber security protection. The Company continues to develop its own technologies and has an active acquisitions program in place.
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Appiphany's filings with the SEC , which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Contact Info: http://www.classidocs.com Media Relations info@ipriskcontrol.com +1-385-212-3295 http://www.ipriskcontrol.com
Source: Appiphany Technologies Holdings Corp.
$APHD NEWS OUT....60M BID .0008x.0009 +50%%%%%%%%
Tuesday, June 20 2017 8:30 AM, EST IP Risk Controls ClassiDocs Releases Encrypted File Detection Functionality GlobeNewswire "Press Releases"
SALT LAKE CITY , June 20, 2017 (GLOBE NEWSWIRE) -- ClassiDocs unveiled new functionality that enables any organization to be notified when a portion of their files have become encrypted usually a harbinger to a Malware or Ransomware infection. With continued proliferation of ransomware infections and their mutations by hackers and some nation-states the risk of a ransomware infection getting past normal defenses continues to grow.
Many of our customers and partners are looking past the prevention boundary and are focusing on the response side. Response is critical in any cyber-security program and having these being automated but guided by data intelligence is significant," stated IP Risk Control (OTCPNK:APHD) President Jason Remillard . While front line defense will always be important, how you respond to actual events ranks very highly in mitigating risk, costs and ultimately the damage done.
The newest functionality leverages the existing distributed agent real estate to monitor file activity not just reads and writes, but what is in them and how they are classified. If a certain percentage of them are detected to be encrypted the administrator can automatically run processes that are appropriate. In most cases, this would mean immediately disconnecting and shutting down the machine, locking out the user in question and sending alerts to the cyber security operations center. Administrators can control the sequence of events and orchestrations in response to the encryption (or ransomware) condition.
ClassiDocs is a leading Data Classification platform that enables End Users and Data Stewards to actively participate in the process of classifying data sets (structured and unstructured) in a user-friendly, efficient and quick process that generally requires little to no end user training or education. The entire solution is quick to deliver value for the organization - with average installation and configuration times to be less than 1 hour from installation to time to value.
By enabling the business to make IT decisions based on a potentially hostile action such as a mass encryption of files - ClassiDocs brings actual data intelligence to the IT and governance teams. In the case of a WannaCry or other related attacks, the ultimate impact of the damage done can be greatly reduced," continues Remillard.
The ability to classify data sets in myriad platforms - with an accurate and up-to-date classification system - is integral for any organization (health care, financial services, manufacturing, government) with private, customer, or financial information to protect. ClassiDocs represents a departure from the regular approaches - with its focus on end-user adoption, simple and rapidly deployable architecture, and native integrations with leading SIEM, EndPoint Security and Governance and Compliance toolsets.
ClassiDocs was acquired by Appiphany Technology Holdings Corp. in April 2017 .
IP Risk Control is Hiring! - http://ipriskcontrol.com/jobs/
Follow news directly at:
http://ipriskcontrol.com/blog/
https://twitter.com/IPRiskControl
About Appiphany Technology Holdings Corp.
Appiphany Technologies (IP Risk Control) (http://www.ipriskcontrol.com) has diversified offerings to deliver global 'best-of-breed' products and technologies that combat counterfeit and theft of global goods, data and cyber security protection. The Company continues to develop its own technologies and has an active acquisitions program in place.
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Appiphany's filings with the SEC , which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Contact Info: http://www.classidocs.com Media Relations info@ipriskcontrol.com +1-385-212-3295 http://www.ipriskcontrol.com
Source: Appiphany Technologies Holdings Corp.
60 MIL BID .0008
monster bid 20+ million .0022
$TAUG BOOOOOOOOOOOM .002 UP!!!!!!!!!!!! +137%%%%%%%%%%%%%
$TAUG BOOOOOOOOOOOM .002 UP!!!!!!!!!!!! +137%%%%%%%%%%%%%
15K ON THE BID.
$TAUG .0015x.0016 thin to .002....highs .002 today.
$TAUG .0015x.0016 thin to .002....highs .002 today.
$TAUG~~++++++100%%% WEEEEEEE...INSIDER BUYING NEWS OUT!
Thursday, June 15 2017 8:00 AM, EST Tauriga Sciences Inc. Discloses Personal Investment of $95,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125 Marketwire "Press Releases"
NEW YORK, NY -- (Marketwired) -- 06/15/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made a personal investment into the Company totaling $95,000 USD at this time. This personal investment was structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent "), for a total of 76,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). The Company will utilize this infusion of working capital for general and administrative purposes; these 76,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
$TAUG~~++++++100%%% WEEEEEEE...INSIDER BUYING NEWS OUT!
Thursday, June 15 2017 8:00 AM, EST Tauriga Sciences Inc. Discloses Personal Investment of $95,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125 Marketwire "Press Releases"
NEW YORK, NY -- (Marketwired) -- 06/15/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made a personal investment into the Company totaling $95,000 USD at this time. This personal investment was structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent "), for a total of 76,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). The Company will utilize this infusion of working capital for general and administrative purposes; these 76,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
$TAUG~.0014x.0015~~NO DILUTION....INSIDER BUYING...+87%, HIT .002 today
Thursday, June 15 2017 8:00 AM, EST Tauriga Sciences Inc. Discloses Personal Investment of $95,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125 Marketwire "Press Releases"
NEW YORK, NY -- (Marketwired) -- 06/15/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made a personal investment into the Company totaling $95,000 USD at this time. This personal investment was structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent "), for a total of 76,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). The Company will utilize this infusion of working capital for general and administrative purposes; these 76,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
$TAUG~.0014x.0015~~NO DILUTION....INSIDER BUYING...+87%, HIT .002 today
Thursday, June 15 2017 8:00 AM, EST Tauriga Sciences Inc. Discloses Personal Investment of $95,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125 Marketwire "Press Releases"
NEW YORK, NY -- (Marketwired) -- 06/15/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made a personal investment into the Company totaling $95,000 USD at this time. This personal investment was structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent "), for a total of 76,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). The Company will utilize this infusion of working capital for general and administrative purposes; these 76,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
$TAUG +87%%%% WEEEEEEEEEEEEEEEEEEEEEEEE
Thursday, June 15 2017 8:00 AM, EST Tauriga Sciences Inc. Discloses Personal Investment of $95,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125 Marketwire "Press Releases"
NEW YORK, NY -- (Marketwired) -- 06/15/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made a personal investment into the Company totaling $95,000 USD at this time. This personal investment was structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent "), for a total of 76,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). The Company will utilize this infusion of working capital for general and administrative purposes; these 76,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
Tauriga's CEO, Seth M. Shaw , expressed, "At this time, I believe it is of great importance to demonstrate to shareholders my unwavering commitment to both restoring and creating long term shareholder value. This $95,000 USD will help the Company satisfy some short term commitments & invoices and enable Tauriga to approach the second half of Calendar Year 2017 with a greater degree of strength, flexibility, and confidence."
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (OTC PINK: TAUG) is a fully reporting life sciences company engaged in the development, marketing, distribution and potential licensing of a broad array of products and technologies that may help individuals who are affected by muscle tension. The Company has already identified potential products and technologies of interest and is actively working towards the goal of creating an innovative product line to launch the business activities of ColluMauxil Therapeutics LLC (The Company's previously announced new planned wholly owned subsidiary). The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. The Company is also prosecuting (as Plaintiff) its ongoing malpractice lawsuit against its predecessor audit firm, for which it's seeking monetary damages in excess of $4,500,000 USD .
$TAUG +87%%%% WEEEEEEEEEEEEEEEEEEEEEEEE
Thursday, June 15 2017 8:00 AM, EST Tauriga Sciences Inc. Discloses Personal Investment of $95,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125 Marketwire "Press Releases"
NEW YORK, NY -- (Marketwired) -- 06/15/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made a personal investment into the Company totaling $95,000 USD at this time. This personal investment was structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent "), for a total of 76,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). The Company will utilize this infusion of working capital for general and administrative purposes; these 76,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
Tauriga's CEO, Seth M. Shaw , expressed, "At this time, I believe it is of great importance to demonstrate to shareholders my unwavering commitment to both restoring and creating long term shareholder value. This $95,000 USD will help the Company satisfy some short term commitments & invoices and enable Tauriga to approach the second half of Calendar Year 2017 with a greater degree of strength, flexibility, and confidence."
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (OTC PINK: TAUG) is a fully reporting life sciences company engaged in the development, marketing, distribution and potential licensing of a broad array of products and technologies that may help individuals who are affected by muscle tension. The Company has already identified potential products and technologies of interest and is actively working towards the goal of creating an innovative product line to launch the business activities of ColluMauxil Therapeutics LLC (The Company's previously announced new planned wholly owned subsidiary). The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. The Company is also prosecuting (as Plaintiff) its ongoing malpractice lawsuit against its predecessor audit firm, for which it's seeking monetary damages in excess of $4,500,000 USD .
$TAUG NEW BID SUPPORT .0014x.0015....insiders buying 76M..form 4 to follow
Thursday, June 15 2017 8:00 AM, EST Tauriga Sciences Inc. Discloses Personal Investment of $95,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125 Marketwire "Press Releases"
NEW YORK, NY -- (Marketwired) -- 06/15/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made a personal investment into the Company totaling $95,000 USD at this time. This personal investment was structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent "), for a total of 76,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). The Company will utilize this infusion of working capital for general and administrative purposes; these 76,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
Tauriga's CEO, Seth M. Shaw , expressed, "At this time, I believe it is of great importance to demonstrate to shareholders my unwavering commitment to both restoring and creating long term shareholder value. This $95,000 USD will help the Company satisfy some short term commitments & invoices and enable Tauriga to approach the second half of Calendar Year 2017 with a greater degree of strength, flexibility, and confidence."
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (OTC PINK: TAUG) is a fully reporting life sciences company engaged in the development, marketing, distribution and potential licensing of a broad array of products and technologies that may help individuals who are affected by muscle tension. The Company has already identified potential products and technologies of interest and is actively working towards the goal of creating an innovative product line to launch the business activities of ColluMauxil Therapeutics LLC (The Company's previously announced new planned wholly owned subsidiary). The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. The Company is also prosecuting (as Plaintiff) its ongoing malpractice lawsuit against its predecessor audit firm, for which it's seeking monetary damages in excess of $4,500,000 USD .
NON SOLICITATION:
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation: expectations, expects, anticipates, believes, hopes, beliefs, plans and objectives regarding the development, use and marketability of products as well as the attainment of certain corporate goals and milestones (i.e. SEC Periodic Filings, Filing of Proxies, etc.). Such forward-looking statements are based on present circumstances and on Tauriga's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which Tauriga has little or no control. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by Tauriga with the Securities and Exchange Commission . This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
CONTACT: Mr. Seth M. Shaw Chairman & Chief Executive Officer email: sshaw@tauriga.com cell # (917) 796 9926 fax # (514) 221 3336
Source: Tauriga Sciences, Inc.
$TAUG NEW BID SUPPORT .0014x.0015....insiders buying 76M..form 4 to follow
Thursday, June 15 2017 8:00 AM, EST Tauriga Sciences Inc. Discloses Personal Investment of $95,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125 Marketwire "Press Releases"
NEW YORK, NY -- (Marketwired) -- 06/15/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made a personal investment into the Company totaling $95,000 USD at this time. This personal investment was structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent "), for a total of 76,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). The Company will utilize this infusion of working capital for general and administrative purposes; these 76,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
Tauriga's CEO, Seth M. Shaw , expressed, "At this time, I believe it is of great importance to demonstrate to shareholders my unwavering commitment to both restoring and creating long term shareholder value. This $95,000 USD will help the Company satisfy some short term commitments & invoices and enable Tauriga to approach the second half of Calendar Year 2017 with a greater degree of strength, flexibility, and confidence."
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (OTC PINK: TAUG) is a fully reporting life sciences company engaged in the development, marketing, distribution and potential licensing of a broad array of products and technologies that may help individuals who are affected by muscle tension. The Company has already identified potential products and technologies of interest and is actively working towards the goal of creating an innovative product line to launch the business activities of ColluMauxil Therapeutics LLC (The Company's previously announced new planned wholly owned subsidiary). The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. The Company is also prosecuting (as Plaintiff) its ongoing malpractice lawsuit against its predecessor audit firm, for which it's seeking monetary damages in excess of $4,500,000 USD .
NON SOLICITATION:
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation: expectations, expects, anticipates, believes, hopes, beliefs, plans and objectives regarding the development, use and marketability of products as well as the attainment of certain corporate goals and milestones (i.e. SEC Periodic Filings, Filing of Proxies, etc.). Such forward-looking statements are based on present circumstances and on Tauriga's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which Tauriga has little or no control. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by Tauriga with the Securities and Exchange Commission . This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
CONTACT: Mr. Seth M. Shaw Chairman & Chief Executive Officer email: sshaw@tauriga.com cell # (917) 796 9926 fax # (514) 221 3336
Source: Tauriga Sciences, Inc.
$TAUG SUPER THIN .0013X.0015
$TAUG~~~NEWS OUT---INSIDER CEO PURCHASED 76MILLION SHARES..+75%% TODAY
FORM 4 TO FOLLOW IN COMING BUSINESS DAYS....
Thursday, June 15 2017 8:00 AM, EST Tauriga Sciences Inc. Discloses Personal Investment of $95,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125 Marketwire "Press Releases"
NEW YORK, NY -- (Marketwired) -- 06/15/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made a personal investment into the Company totaling $95,000 USD at this time. This personal investment was structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent "), for a total of 76,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). The Company will utilize this infusion of working capital for general and administrative purposes; these 76,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
Tauriga's CEO, Seth M. Shaw , expressed, "At this time, I believe it is of great importance to demonstrate to shareholders my unwavering commitment to both restoring and creating long term shareholder value. This $95,000 USD will help the Company satisfy some short term commitments & invoices and enable Tauriga to approach the second half of Calendar Year 2017 with a greater degree of strength, flexibility, and confidence."
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (OTC PINK: TAUG) is a fully reporting life sciences company engaged in the development, marketing, distribution and potential licensing of a broad array of products and technologies that may help individuals who are affected by muscle tension. The Company has already identified potential products and technologies of interest and is actively working towards the goal of creating an innovative product line to launch the business activities of ColluMauxil Therapeutics LLC (The Company's previously announced new planned wholly owned subsidiary). The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. The Company is also prosecuting (as Plaintiff) its ongoing malpractice lawsuit against its predecessor audit firm, for which it's seeking monetary damages in excess of $4,500,000 USD .
NON SOLICITATION:
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation: expectations, expects, anticipates, believes, hopes, beliefs, plans and objectives regarding the development, use and marketability of products as well as the attainment of certain corporate goals and milestones (i.e. SEC Periodic Filings, Filing of Proxies, etc.). Such forward-looking statements are based on present circumstances and on Tauriga's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which Tauriga has little or no control. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by Tauriga with the Securities and Exchange Commission . This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
CONTACT: Mr. Seth M. Shaw Chairman & Chief Executive Officer email: sshaw@tauriga.com cell # (917) 796 9926 fax # (514) 221 3336
Source: Tauriga Sciences, Inc.
$TAUG SUPER THIN. .0014X.0015
$TAUG~~~NEWS OUT---INSIDER CEO PURCHASED 76MILLION SHARES..+75%% TODAY
FORM 4 TO FOLLOW IN COMING BUSINESS DAYS....
Thursday, June 15 2017 8:00 AM, EST Tauriga Sciences Inc. Discloses Personal Investment of $95,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125 Marketwire "Press Releases"
NEW YORK, NY -- (Marketwired) -- 06/15/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made a personal investment into the Company totaling $95,000 USD at this time. This personal investment was structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent "), for a total of 76,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). The Company will utilize this infusion of working capital for general and administrative purposes; these 76,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
Tauriga's CEO, Seth M. Shaw , expressed, "At this time, I believe it is of great importance to demonstrate to shareholders my unwavering commitment to both restoring and creating long term shareholder value. This $95,000 USD will help the Company satisfy some short term commitments & invoices and enable Tauriga to approach the second half of Calendar Year 2017 with a greater degree of strength, flexibility, and confidence."
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (OTC PINK: TAUG) is a fully reporting life sciences company engaged in the development, marketing, distribution and potential licensing of a broad array of products and technologies that may help individuals who are affected by muscle tension. The Company has already identified potential products and technologies of interest and is actively working towards the goal of creating an innovative product line to launch the business activities of ColluMauxil Therapeutics LLC (The Company's previously announced new planned wholly owned subsidiary). The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. The Company is also prosecuting (as Plaintiff) its ongoing malpractice lawsuit against its predecessor audit firm, for which it's seeking monetary damages in excess of $4,500,000 USD .
NON SOLICITATION:
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation: expectations, expects, anticipates, believes, hopes, beliefs, plans and objectives regarding the development, use and marketability of products as well as the attainment of certain corporate goals and milestones (i.e. SEC Periodic Filings, Filing of Proxies, etc.). Such forward-looking statements are based on present circumstances and on Tauriga's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which Tauriga has little or no control. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by Tauriga with the Securities and Exchange Commission . This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
CONTACT: Mr. Seth M. Shaw Chairman & Chief Executive Officer email: sshaw@tauriga.com cell # (917) 796 9926 fax # (514) 221 3336
Source: Tauriga Sciences, Inc.
NEVER GOOD WHEN VFIN SHOWS UP
$14 MILLION FINANCING - Thursday, June 15 2017 9:00 AM, EST Lithium Exploration Group Announces Agreement on $14M Financing for White Top Oil and Gas Project PR Newswire "Press Releases US - English"
TEMPE, Arizona , June 15, 2017 /PRNewswire/ --
Lithium Exploration Group Inc. (OTC: LEXG) announced today that its partners at White Top Oil and Gas have reached a verbal agreement on a $14M investment that would fund the final acquisition of the field in Louisiana , and fund the first six drilling targets. This proposed investment is from a New York -based private equity firm and is being made directly into White Top Oil and Gas and thus will not be dilutive to LEXG shareholders.
"I was on a call with our partners at White Top and the investor yesterday afternoon and, with only a few small considerations in the final documentation, the goal is to close the transaction in July," commented CEO Alex Walsh . "We are not directly involved in this transaction but we benefit, because, as soon as the acquisition is finalized, we begin to collect checks on our 3% overriding royalty. As they drill additional wells that royalty stream goes up. The recent discovery of the overhang has significantly expedited the funding process and we are all excited to move this project forward."
About Lithium Exploration Group
Lithium Exploration Group is a US-based exploration and development company focused on the acquisition and development potential of lithium brines and other precious metals that demonstrate high probability for near-term production. Currently the company is focused testing the Sonic Cavitation Ltd. technology and the acquisition of oil and gas related assets in the US and Canada . Lithium Exploration Group is traded on the OTC Markets under the symbol LEXG.
Website: http://www.lithiumexplorationgroup.com.
Safe Harbor Statement
This news release contains "forward-looking statements". Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future testing of the ultrasonic technology.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of lithium prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements.
Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission .
Contact Info Shanon Chilson 480-641-4790 info@lithiumexplorationgroup.com
SOURCE Lithium Exploration Group Inc.
CEO PURCHASED 76 MILLION SHARES - Thursday, June 15 2017 8:00 AM, EST Tauriga Sciences Inc. Discloses Personal Investment of $95,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125 Marketwire "Press Releases"
NEW YORK, NY -- (Marketwired) -- 06/15/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made a personal investment into the Company totaling $95,000 USD at this time. This personal investment was structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent "), for a total of 76,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). The Company will utilize this infusion of working capital for general and administrative purposes; these 76,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
Tauriga's CEO, Seth M. Shaw , expressed, "At this time, I believe it is of great importance to demonstrate to shareholders my unwavering commitment to both restoring and creating long term shareholder value. This $95,000 USD will help the Company satisfy some short term commitments & invoices and enable Tauriga to approach the second half of Calendar Year 2017 with a greater degree of strength, flexibility, and confidence."
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (OTC PINK: TAUG) is a fully reporting life sciences company engaged in the development, marketing, distribution and potential licensing of a broad array of products and technologies that may help individuals who are affected by muscle tension. The Company has already identified potential products and technologies of interest and is actively working towards the goal of creating an innovative product line to launch the business activities of ColluMauxil Therapeutics LLC (The Company's previously announced new planned wholly owned subsidiary). The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. The Company is also prosecuting (as Plaintiff) its ongoing malpractice lawsuit against its predecessor audit firm, for which it's seeking monetary damages in excess of $4,500,000 USD .
NON SOLICITATION:
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation: expectations, expects, anticipates, believes, hopes, beliefs, plans and objectives regarding the development, use and marketability of products as well as the attainment of certain corporate goals and milestones (i.e. SEC Periodic Filings, Filing of Proxies, etc.). Such forward-looking statements are based on present circumstances and on Tauriga's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which Tauriga has little or no control. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by Tauriga with the Securities and Exchange Commission . This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
CONTACT: Mr. Seth M. Shaw Chairman & Chief Executive Officer email: sshaw@tauriga.com cell # (917) 796 9926 fax # (514) 221 3336
Source: Tauriga Sciences, Inc.
.0006 almost gone.....LETS MOVE THIS!
NOT MUCH .001'S LEFT
NICE BID .001
35m volume first 15 min +160%